ATE180495T1 - Unterscheidung von htlv-i und htlv-ii unter verwendung von synthetischen peptiden - Google Patents

Unterscheidung von htlv-i und htlv-ii unter verwendung von synthetischen peptiden

Info

Publication number
ATE180495T1
ATE180495T1 AT92915142T AT92915142T ATE180495T1 AT E180495 T1 ATE180495 T1 AT E180495T1 AT 92915142 T AT92915142 T AT 92915142T AT 92915142 T AT92915142 T AT 92915142T AT E180495 T1 ATE180495 T1 AT E180495T1
Authority
AT
Austria
Prior art keywords
htlv
differentiation
synthetic peptides
antibodies
peptides
Prior art date
Application number
AT92915142T
Other languages
English (en)
Inventor
Jessie W Shih
John D Burczak
Helen H Lee
Debra L O'donnell
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE180495T1 publication Critical patent/ATE180495T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92915142T 1991-07-10 1992-07-08 Unterscheidung von htlv-i und htlv-ii unter verwendung von synthetischen peptiden ATE180495T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72776591A 1991-07-10 1991-07-10

Publications (1)

Publication Number Publication Date
ATE180495T1 true ATE180495T1 (de) 1999-06-15

Family

ID=24923975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92915142T ATE180495T1 (de) 1991-07-10 1992-07-08 Unterscheidung von htlv-i und htlv-ii unter verwendung von synthetischen peptiden

Country Status (10)

Country Link
EP (1) EP0677117B1 (de)
JP (1) JP3421336B2 (de)
AT (1) ATE180495T1 (de)
AU (1) AU2319492A (de)
CA (1) CA2113099C (de)
DE (1) DE69229284T2 (de)
DK (1) DK0677117T3 (de)
ES (1) ES2134810T3 (de)
GR (1) GR3030853T3 (de)
WO (1) WO1993001316A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773211A (en) * 1991-07-10 1998-06-30 Abbott Laboratories Differentiation of HTLV-I and HTLV-II using synthetic peptides
JP3506252B2 (ja) * 1992-02-24 2004-03-15 ジェネラブス・テクノロジーズ・インコーポレイテッド Ｈｔｌｖ−ｉ／ｈｔｌｖ−ｉｉの分析及び方法
US6406841B1 (en) * 1993-07-01 2002-06-18 Abbott Laboratories Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides
AU1443695A (en) * 1993-12-20 1995-07-10 Abbott Laboratories Differentiation of htlv-i and htlv-ii using synthetic peptides
JP2001510553A (ja) * 1995-06-05 2001-07-31 アボツト・ラボラトリーズ 組換え蛋白質を用いたｈｔｌｖ抗体の検出法
US6020122A (en) * 1995-06-07 2000-02-01 Abbott Laboratories Hepatitis C virus second envelope (HCV-E2) glycoprotein expression system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614366A (en) * 1986-12-31 1997-03-25 Genelabs Technologies, Inc. HTLV-I peptide antigens and kit
US5017687A (en) * 1988-03-10 1991-05-21 Virovahl, S.A. Peptides for the detection of HTLV-1 infection
US5003043A (en) * 1988-05-25 1991-03-26 Triton Biosciences Inc. Peptides representing epitopic sites for the major HTLV-I envelope protein, antibodies thereto, and uses thereof
SE8900721D0 (sv) * 1989-03-02 1989-03-02 Blomberg Jonas Methods for detection of antibodies to
SE467542B (sv) * 1989-06-13 1992-08-03 Syntello Ab Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar
US5283320A (en) * 1989-11-13 1994-02-01 Syntello Ab Peptides for HTLV-2 infection diagnosis of, therapy for, vaccination against, for distinguishing between HTLV-1 and HTLV-2 infections and antibodies derived therefrom
FI910245A (fi) * 1990-01-24 1991-07-25 United Biomedical Inc Syntetiska peptidkompositioner med immunoreaktivitet mot htlv-antikroppar.
NZ238855A (en) * 1990-07-18 1994-03-25 Iaf Biochem Int Peptides, mixtures thereof and compositions useful for detecting htlv-i and htlv-ii infections
JPH04164097A (ja) * 1990-10-24 1992-06-09 Kuraray Co Ltd ペプチドおよびその用途

Also Published As

Publication number Publication date
DK0677117T3 (da) 1999-11-29
ES2134810T3 (es) 1999-10-16
EP0677117A1 (de) 1995-10-18
CA2113099C (en) 2003-09-23
JP3421336B2 (ja) 2003-06-30
EP0677117B1 (de) 1999-05-26
DE69229284D1 (de) 1999-07-01
CA2113099A1 (en) 1993-01-21
JPH06510988A (ja) 1994-12-08
EP0677117A4 (de) 1995-11-02
WO1993001316A1 (en) 1993-01-21
AU2319492A (en) 1993-02-11
DE69229284T2 (de) 1999-12-16
GR3030853T3 (en) 1999-11-30

Similar Documents

Publication Publication Date Title
DE69009556D1 (de) Apparat zur Erzeugung von Stereobildern.
DE69228701T2 (de) Fragmente von Prion Proteinen.
NO954643D0 (no) Antistoff-fragment samt anvendelse og framgangsmåte for framstilling av samme
DE68918605D1 (de) Verfahren zur Speicherung und Übertragung von Bilddaten als Bilddatengruppe, passend zur Bildsuche.
ATE184882T1 (de) Materialien und methoden zur schädlingsbekämpfung
DE68923611D1 (de) Verfahren und apparat zur beförderung von gegenständen.
DE69019621D1 (de) Ein automatisches System zum Anpassen der Ausgangsimpedanz von schnellen CMOS-Treibern.
DE3853014D1 (de) Apparat zur Prüfung von Einkäufen.
DE69019753T3 (de) Verfahren zur verwendung von gashilfe während des giessens von kunststoffgegenständen.
DE68915006D1 (de) System zum Generieren von Musterdaten.
DE69300024D1 (de) Vorrichtung zur Erzeugung von Bezugsspannungen.
DE69128273T2 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
DE3686100D1 (de) Apparat zur pruefung von objekten.
DE3850592D1 (de) Apparat zur Vorbereitung von Briefen.
DE68909385D1 (de) Apparat zur Herstellung von Perlen.
DE3766690D1 (de) Vorrichtung zur beeinflussung der steuerzeiten von ventilen.
DE69229284T2 (de) Unterscheidung von htlv-i und htlv-ii unter verwendung von synthetischen peptiden
DE69020985D1 (de) Apparat zur Trennung von Lösungen.
DE68913283D1 (de) Verfahren zur Abtrennung von Kohlendioxid.
DE3850513D1 (de) Apparat zur Verarbeitung von Briefen.
DE69534077D1 (de) Verwendung von methoden zur identifizierung von hydrophilen signal-oligopeptiden
DE69107519D1 (de) Verfahren zur katalytischen Cyclizierung von Alkenylbenzolen.
DE68908728D1 (de) System zum Generieren von Musterdaten.
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.
DE69003693D1 (de) Verfahren zur Expression von Biotin in Bacillus sphaericus.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee